| NCT ID | NCT04804878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Morehouse School of Medicine |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2018-04-05 |
| Primary Completion | 2035-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2018-04-05 with a primary completion date of 2035-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and "personalized medicine" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of African American cancer patients, survivors, or those at risk of having cancer. This is not a treatment trial, but a longitudinal study designed to create a centralized cancer biorepository for precision medicine.
Eligibility Criteria
Inclusion Criteria: 1. 18 years of age and older. 2. Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis. 3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages Exclusion Criteria: None \-
Contact & Investigator
James W Lillard, PhD
PRINCIPAL INVESTIGATOR
Morehouse School of Medicine
Frequently Asked Questions
Who can join the NCT04804878 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04804878 currently recruiting?
Yes, NCT04804878 is actively recruiting participants. Contact the research team at totalcancercare@msm.edu for enrollment information.
Where is the NCT04804878 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT04804878 clinical trial?
NCT04804878 is sponsored by Morehouse School of Medicine. The principal investigator is James W Lillard, PhD at Morehouse School of Medicine. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.